ST. LOUIS, June 29 /PRNewswire-FirstCall/ -- GenoMed, Inc. will conduct a live press conference on http://www.MN1.com at 9:30am Central Time Friday, June 30th, 2006. Interested parties may go to http://www.MN1.com and download the free player enabling them to listen in for management's review of operations and discussion of future prospects. This live broadcast is available to anyone at any computer connected to the Internet. This should prove to be an eye-opening and enriching experience for all of those associated with GenoMed .
About MN1.com
MN1.com is the only online destination that brings real microcap news to investors and features live interaction with companies from the Bulletin Board, Pink Sheets, and Amex. Featuring Live Press Conferences, All-Day Live Trading Commentary, Analyst Profiles, Interactive Forums, News Items, and "The MicroBlog," MN1.com gives microcap investors the information source necessary to trade in the markets. MN1.com boasts being the largest true news company reporting on microcap traded stocks.
About GenoMed
GenoMed is a St. Louis-based Next Generation Disease Management company that uses genomics to improve patient outcomes. Besides kidney disease, GenoMed has novel approaches to many additional diseases, including a general viral antidote. Anyone can download GenoMed's protocol for avian influenza or West Nile virus from GenoMed's website, http://www.genomed.com , at any time of day or night.
'Safe Harbor' Statement under the Private Securities Litigation Reform Act of 1995: This press release may contain certain forward-looking statements within the meaning of Section 27A of the Securities and Exchange Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainties. Although MN1 Inc. believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any assumption could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this press release will prove to be accurate. In light of the significant uncertainties inherent in the forward- looking statements included herein, the inclusion should not be regarded as a representation by MN1 Inc. or any other person that the objective and plans of MN1 Inc. will be achieved.
GenoMedCONTACT: David Moskowitz MD of GenoMed, Inc., +1-314-983-9938
Web site: http://www.genomed.com//
